Checkpoint Therapeutics, Inc. has announced an update on its planned merger with Sun Pharmaceutical Industries, Inc. The two companies have entered into an amended Agreement and Plan of Merger as of April 14, 2025. According to the terms of the merger, Checkpoint will merge with Snoopy Merger Sub, Inc., a wholly owned subsidiary of Sun Pharma, with Checkpoint continuing as the surviving entity and becoming a wholly owned subsidiary of Sun Pharma. The merger is expected to close on or about May 30, 2025, pending the required stockholder vote and other closing conditions. A special meeting for Checkpoint stockholders to vote on the merger is scheduled for May 28, 2025.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。